none
Gómez-Peralta, F., Abreu, C., Rizzo, M. (2023). GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 37(8), 108553 [10.1016/j.jdiacomp.2023.108553].
GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms
Rizzo, Manfredi
2023-08-01
Abstract
none
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2023 JDC 2.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
347.35 kB
Formato
Adobe PDF
|
347.35 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
